These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 7475792)

  • 1. Intravenous anti-D immunoglobulin for childhood acute immune thrombocytopenic purpura.
    Zunich KM; Harkonen WS; Woloski M; Kingsbury L
    Lancet; 1995 Nov; 346(8986):1363-5. PubMed ID: 7475792
    [No Abstract]   [Full Text] [Related]  

  • 2. Randomised trial of intravenous immunoglobulin G, intravenous anti-D, and oral prednisone in childhood acute immune thrombocytopenic purpura.
    Blanchette V; Imbach P; Andrew M; Adams M; McMillan J; Wang E; Milner R; Ali K; Barnard D; Bernstein M
    Lancet; 1994 Sep; 344(8924):703-7. PubMed ID: 7915773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IVIG, anti-D or oral prednisolone in acute ITP?
    Indian Pediatr; 1995 Feb; 32(2):263-4. PubMed ID: 8635800
    [No Abstract]   [Full Text] [Related]  

  • 4. A cost-utility analysis of treatment for acute childhood idiopathic thrombocytopenic purpura (ITP).
    O'Brien SH; Ritchey AK; Smith KJ
    Pediatr Blood Cancer; 2007 Feb; 48(2):173-80. PubMed ID: 16550529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of acute immune thrombocytopenic purpura in children--intravenous immunoglobulin or treatment with corticosteroids?].
    Masłowska E; Wysocki M; Michalak-Nowaczyk A
    Pediatr Pol; 1996 Jan; 71(1):25-9. PubMed ID: 8966063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune thrombocytopenic purpura: why treat?
    Nugent DJ
    J Pediatr; 1999 Jan; 134(1):3-4. PubMed ID: 9880438
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of childhood acute immune thrombocytopenic purpura with anti-D immune globulin or pooled immune globulin.
    Tarantino MD; Madden RM; Fennewald DL; Patel CC; Bertolone SJ
    J Pediatr; 1999 Jan; 134(1):21-6. PubMed ID: 9880444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous (IV) anti-D and IV immunoglobulin achieve acute platelet increases by different mechanisms: modulation of cytokine and platelet responses to IV anti-D by FcgammaRIIa and FcgammaRIIIa polymorphisms.
    Cooper N; Heddle NM; Haas M; Reid ME; Lesser ML; Fleit HB; Woloski BM; Bussel JB
    Br J Haematol; 2004 Feb; 124(4):511-8. PubMed ID: 14984503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute immune (idiopathic) thrombocytopenic purpura in childhood.
    Tarantino MD
    Blood Rev; 2002 Mar; 16(1):19-21. PubMed ID: 11913988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A multicenter study of the treatment of childhood chronic idiopathic thrombocytopenic purpura with anti-D.
    Andrew M; Blanchette VS; Adams M; Ali K; Barnard D; Chan KW; DeVeber LB; Esseltine D; Israels S; Korbrinsky N
    J Pediatr; 1992 Apr; 120(4 Pt 1):522-7. PubMed ID: 1313096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous immunoglobulin G and anti-D as therapeutic interventions in immune thrombocytopenic purpura.
    Blanchette V; Carcao M
    Transfus Sci; 1998 Sep; 19(3):279-88. PubMed ID: 10351140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-D immunoglobulin in children with newly diagnosed immune thrombocytopenic purpura: a pilot study.
    Monteleone PM; Vander Heyden MA; Steele DA; Kelleher JF
    Haematologica; 2000 Aug; 85(8):887-8. PubMed ID: 10942950
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of severe autoimmune thrombocytopenic purpura.
    Carradice D
    Lancet; 2002 Jun; 359(9325):2279; author reply 2279-80. PubMed ID: 12103321
    [No Abstract]   [Full Text] [Related]  

  • 14. A prospective, randomized trial of high-dose intravenous immune globulin G therapy, oral prednisone therapy, and no therapy in childhood acute immune thrombocytopenic purpura.
    Blanchette VS; Luke B; Andrew M; Sommerville-Nielsen S; Barnard D; de Veber B; Gent M
    J Pediatr; 1993 Dec; 123(6):989-95. PubMed ID: 8229536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of action of IVIG and anti-D in ITP.
    Lazarus AH; Crow AR
    Transfus Apher Sci; 2003 Jun; 28(3):249-55. PubMed ID: 12725951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Use of anti-D (Rh) IgG or intramuscular polyvalent human immunoglobulin in the treatment of chronic autoimmune thrombocytopenic purpura].
    Vizcaíno G; Diez-Ewald M; Arteaga-Vizcaíno M; Torres E
    Invest Clin; 1992; 33(4):165-74. PubMed ID: 1338940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet production and platelet destruction: assessing mechanisms of treatment effect in immune thrombocytopenia.
    Barsam SJ; Psaila B; Forestier M; Page LK; Sloane PA; Geyer JT; Villarica GO; Ruisi MM; Gernsheimer TB; Beer JH; Bussel JB
    Blood; 2011 May; 117(21):5723-32. PubMed ID: 21389318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Danazol therapy for chronic immune-mediated thrombocytopenic purpura in a patient with common variable immunodeficiency.
    Saulsbury FT; Bringelsen KA
    Am J Pediatr Hematol Oncol; 1991; 13(3):326-9. PubMed ID: 1793160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of anti-D in immune thrombocytopenic purpura as a means to prevent splenectomy: case reports from two University Hospital Medical Centers.
    Waintraub SE; Brody JI
    Semin Hematol; 2000 Jan; 37(1 Suppl 1):45-9. PubMed ID: 10676925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A review of anti-D treatment of childhood idiopathic thrombocytopenic purpura.
    Kjaersgaard M; Hasle H
    Pediatr Blood Cancer; 2006 Oct; 47(5 Suppl):717-20. PubMed ID: 16933265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.